Furthermore, cannabigerol, a non-psychotropic cannabis-derived cannabinoid, reduces colon cancer progression in vivo and selectively inhibits the growth of CRC cells via interaction with TRPM8 [136]. Here, TRPM8 is linked to colorectal carcinoma.